Check in throughout the month to learn more about the latest treatment pearls and research findings in DermIQ’s spotlight on atopic dermatitis.
Are you up to date on your recent atopic dermatitis knowledge? Dermatology Times’ newest DermIQ series will feature recent case studies, clinical trial research, treatment pearls from leaders in the field, and more, with the opportunity to test your knowledge with a quiz at the end.
To prepare yourself and catch up on the most recent atopic dermatitis data, review our comprehensive resources below.
Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.
Efficacy of 1% colloidal oatmeal cream was similar to prescription barrier cream in treating mild to moderate atopic dermatitis.
Peter Lio, MD, offers perspectives on topical steroid withdrawal, also known as red skin syndrome or topical steroid addiction.
Christopher Bunick, MD, PhD, and Ruth Ann Vleugels, MD, MPD, MBA, discuss the results of multiple studies analyzing the incident rates and safety of Janus Kinase (JAK) inhibitors in the treatment of atopic dermatitis.
Jennifer Holman, MD, FAAD, and her patient Audrey Dean discuss the impact of atopic dermatitis on quality of life, emphasizing how shared decision-making and new therapeutic evolutions have improved outcomes and daily life.
James Q Del Rosso, DO; Raj Chovatiya, MD, PhD; and Lisa Swanson, MD, review and discuss review the practical and clinical implications of the itch and pruritus data from the phase 3 TRuE-AD1 and TRuE-AD2 trials.
Peter Lio, MD, discusses pearls and takeaways from the atopic dermatitis panel he participated in at the 2023 Society of Pediatric Dermatology meeting.
In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.
Mona Shahriari, MD, discusses what dermatologists and patients with atopic dermatitis can expect as we transition from winter to spring, as well as new and emerging treatments and technologies for managing atopic dermatitis that she’s looking ahead to as the year progresses.
Do you have an interesting case or topic to discuss? Email us at DTEditor@mmhgroup.com to submit.